A recent study suggests higher doses of Vitamin D3 supplementation during early childhood may reduce the risk of internalizing psychiatric symptoms in later years. The study, a part of the VIDI trial, observed the impact of the standard 10 µg and a tripled 30 µg dose of Vitamin D on children from the age of two weeks to two years.